Kidney Injury Molecule Biomarker

Kidney injury molecule biomarker detects proximal tubular damage preceding serum creatinine elevations. Early detection enables intervention preventing severe injury. Sensitivity and specificity exceed traditional renal markers. Rapid turnaround enables timely clinical decisions. Mechanistic information guides therapeutic intervention.

Clinical utility assessment confirms biomarker value. Regulatory guidance establishes acceptable kidney injury molecule levels. Post-approval monitoring employs kidney injury molecules. Emerging kidney-injury biomarkers improve predictive value. Quality standardisation ensures consistent results.